24 Jul, 16:14 - Indian

SENSEX 80148.88 (-0.35)

Nifty 50 24413.5 (-0.27)

Nifty Bank 51317 (-0.89)

Nifty IT 40115.05 (0.18)

Nifty Midcap 100 56872.75 (1.04)

Nifty Next 50 71844.65 (0.30)

Nifty Pharma 20908.5 (0.74)

Nifty Smallcap 100 18723.5 (1.76)

24 Jul, 16:14 - Global

NIKKEI 225 39154.85 (-1.11)

HANG SENG 17311.05 (-0.91)

DOW JONES 40358.09 (-0.14)

S&P 5555.74 (-0.16)

Login/Signup

Ion Exchange (India) Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 500214 | NSE Symbol : IONEXCHANG | ISIN : INE570A01022 | Industry : Capital Goods-Non Electrical Equipment |


Board Meeting
Announcement Date Date Of Meeting Purpose
19-Jul-2024 02-Aug-2024 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve Pursuant to Regulation 29 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a Meeting of the Board of Directors of the Company will be held on Friday 02nd August 2024 inter-alia to consider and approve the unaudited financial results for the first quarter ended 30th June 2024.
17-May-2024 29-May-2024 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Audited Financial Results for the Financial Year ended 31st March 2024 and recommend dividend if any. Outcome of Board Meeting held on 29th May , 2024. (As Per BSE Announcement dated on 29.05.2024)
21-Mar-2024 21-Mar-2024 Re-appointment of Mr. Dinesh Sharma and Mr. Aankur Patni as Executive Directors of the Company.
15-Jan-2024 25-Jan-2024 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Unaudited Results for the quarter ended 31st December 2023. Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis and Limited Review Report for the third quarter ended 31st December, 2023 which have been approved by the Board of Directors at its meeting held today i.e. 25th January, 2024. Un-audited results for the quarter ended 31st December, 2023 (As per BSE Announcement Dated on 25/01/2024)
16-Oct-2023 27-Oct-2023 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve unaudited financial results for the second quarter and half year ended 30th September 2023. Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis, Segment wise Revenue, Results and Capital Employed, Statement of Assets and Liabilities, Statement of Cash Flow and Limited Review Report for the Second quarter and half year ended 30th September, 2023 which have been approved by the Board of Directors at its meeting held today i.e. 27th October, 2023. Results - For the quarter ended 30th September 2023 (As per BSE Announcement Dated on 27/10/2023) Financial Results - Newspaper Publication. (As Per BSE Announcement Dated on 30/10/2023)
14-Jul-2023 26-Jul-2023 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 inter alia to consider and approve the Unaudited Financial Results for the First Quarter ended 30th June 2023. Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis and Limited Review Report for the first quarter ended 30th June, 2023 which have been approved by the Board of Directors at its meeting held today i.e. 26th July, 2023. Further, the Board of Directors at its aforesaid meeting, have approved the appointment of Mr. Sanjay Joshi as an Additional Director in the capacity of Independent Director of the Company for a period of 5 years subject to approval of members of the Company. A separate letter in this regard is being issued by the Company pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 along with the details prescribed in the SEBI circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015. The meeting of the Board of Directors of the Company commenced at 11:15 a.m. and concluded at 04.00 p.m. Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (LODR) Regulations, 2015, we submit herewith the unaudited financial Results on Standalone and Consolidated basis and Limited Review Report for the first Quarter ended 30th June, 2023. We wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 26th July, 2023, has considered and approved, the appointment of Mr. Sanjay Joshi as an additional director in the capacity of Independent Director of the Company for a period of 5 years subject to the approval of Members of the Company. (As Per BSE Announcement dated on 26.07.2023)
14-Jun-2023 14-Jun-2023 The Board of Directors of Ion Exchange (India) Limited ('IEIL'/ 'the Company') at its Meeting held today i.e. 14th June, 2023 has considered and approved amended Scheme of Amalgamation of Ion Exchange Projects and Engineering Limited ('IEPEL') with the Company ('the Amended Scheme'). The Amended Scheme is subject to necessary statutory and regulatory approvals including the approvals of the National Company Law Tribunal/other regulatory authority and the respective Shareholders of each of the companies involved in the Amended Scheme. We enclose herewith as Annexure 1 the details required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 for the above-mentioned Amended Scheme.
17-May-2023 26-May-2023 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 inter alia to consider and approve the Audited Financial Results for the Financial Year ended 31st March 2023 and recommend dividend if any. Kindly take the same on your record. Pursuant to Regulation 33 and Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Audited Standalone and Consolidated Financial Results, Segment wise revenue results, Capital Employed and Statement of Assets & Liabilities and Cash flow Statement for the financial year ended March 31, 2023 duly approved by the Board of Directors at its meeting held today i.e. May 26, 2023 The meeting of the Board of Directors of the Company commenced at 11:00 a.m. and concluded at 6.30 p.m. Pursuant to Regulation 42 of SEBI (LODR) Regulation, 2015, we wish to inform you that the Board of Directors of Company, at its Board Meeting held today i.e. 26th May, 2023, have fixed the record date as Monday, 12th June, 2023 for the purpose of sub-division/split of the face value of the equity shares of the Company from existing Rs.10 (Rupees Ten only) per Equity share to Re.1 (Rupee One Only) per Equity share. (As per BSE Announcement Dated on 26/05/2023) We submit herewith clarification on rate of dividend recommended by Board of Directors. With reference to our earlier letters dated 26th May, 2023 and 14th July, 2023 respectively, we wish to clarify that the Board of Directors at their meeting held on 26th May, 2023 had recommended a Dividend of Rs.12.50 (125%) per Equity Share of face value of Rs.10/- each for the financial year 2022-23. However, w.e.f 12th June, 2023 (record date), 1 Equity share of the face value of Rs. 10/- per share has been sub-divided into 10 Equity shares of face value of Re. 1/- per share. Therefore, the rate of dividend is adjusted according to Rs. 1.25 (125%) per Equity shares of Face value of Re.1 each. Hope this clarifies the matter (As Per BSE Announcement Dated on 19.07.2023)
30-Mar-2023 20-Apr-2023 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2023 inter alia to consider and approve Pursuant to Regulation 29 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that a Meeting of the Board of Directors of the Company will be held on Thursday 20th April 2023 to consider and approve alteration of equity share capital of the Company by way of splitting its existing equity shares pursuant to the provisions of Section 61(1)(d) of Companies Act 2013 and fixing respective dates thereto including postal ballot activity schedule. Stock Split (As per BSE Bulletin dated on 31/03/2023) The Board of Directors of the Company, at its Meeting held today, i.e. 20th April, 2023, has inter alia, considered and approved the following: 1. Sub-division of 1 Equity share of the Company having face value of INR 10/- each into 10 (Ten) equity shares having face value of INR 1/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company; 2. Amendments in the Capital Clause of the Memorandum of Association of the Company and Articles of Association of the Company, subject to approval of the Shareholders of the Company. The record date for the sub-division of equity shares shall be decided by the Board and will be intimated to the exchanges. (As Per BSE Announcement Dated on 20.04.2023)
20-Mar-2023 23-Mar-2023 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/03/2023 inter alia to consider and approve the Scheme of Amalgamation between Ion Exchange Projects and Engineering Limited (Transferor Company) with Ion Exchange (India) Limited (Transferee Company) subject to necessary approval /consents / sanctions and permissions of the shareholders and /or creditors of the Company of the National Company Law Tribunal (Tribunal) constituted under the provisions of the Companies Act 2013 Securities Exchange Board of India BSE Limited NSE Limited and such other approval/permissions of any other competent authority as may be applicable. The Board of Directors of Ion Exchange (India) Limited ('IEIL'/ 'the Company') at its Meeting held on 23rd March 2023, has considered and approved a Scheme of Amalgamation ('the Scheme') for merger of Ion Exchange Projects and Engineering Limited ('IEPEL') subsidiary Company with the Company. The Scheme is subject to necessary statutory and regulatory approvals including the approvals of the National Company Law Tribunal/other regulatory authority and the respective Shareholders of each of the companies involved in the Scheme. We enclose herewith as Annexure 1 the details required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 for the above-mentioned Scheme. (As per BSE Announcement Dated on 24/03/2023)
20-Jan-2023 03-Feb-2023 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 inter alia to consider and approve 1. Unaudited Financial Results for the Third Quarter ended 31st December 2022; and 2. Approval of Scheme of amalgamation between Global Composites and Structurals Limited (Transferor Company No.1) and Ion Exchange Environment Management Limited (Transferor Company No.2) and Ion Exchange (India) Limited (Transferee Company) subject to necessary approval / consents / sanctions and permissions of the shareholders and / or creditors of the Company of the National Company Law Tribunal (Tribunal) constituted under the provisions of the Companies Act 2013 Securities Exchange Board of India BSE Limited National Stock Exchange of India Limited (NSE) and such other approval/ permissions of any other competent authority as may be applicable. Kindly take the same on your record. Pursuant to Regulation 33 and Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis and Limited Review Report for the third quarter ended 31st December, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 3rd February, 2023. The Board of Directors of Ion Exchange (India) Limited ('IEL'/ 'the Company') at its Meeting held today, has considered and approved a Scheme of Amalgamation for merger of Global Composites & Structurals Limited ('GCSL') and Ion Exchange Environment Management Limited ('IEEML') with the Company ('the Scheme'). GCSL and IEEML are Wholly-owned Subsidiaries of the Company. The Scheme is subject to necessary statutory and regulatory approvals including the approvals of the National Company Law Tribunal/other regulatory authority and the respective Shareholders of each of the companies involved in the Scheme. We enclose herewith as Annexure 1 the details required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 for the above mentioned Scheme. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and Para A of Part A of Schedule III to the said Regulations, we wish to inform that the Board of Directors of the Company at its meeting held today i.e. February 3, 2023, based on the recommendation of Nomination and Remuneration Committee and approval of the Audit Committee, approved the appointment of Mr. Vasant Naik as Group Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from February 3, 2023 in place of Mr. Nandkumar Manohar Ranadive, the current Group Chief Financial officer on his reaching age of superannuation. (As Per BSE Announcement dated on 03.02.2023)
27-Oct-2022 09-Nov-2022 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve the Unaudited Financial Results for the Second Quarter ended 30th September 2022. Pursuant to Regulation 33 and Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis, Segment wise Revenue, Results and Capital Employed, Statement of Assets and Liabilities, Statement of Cash Flow and Limited Review Report for the Second quarter and half year ended 30th September, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 9th November, 2022. The meeting of the Board of Directors of the Company commenced at 11:00 a.m. and concluded at 4.15 p.m. (As Per BSE Announcement Dated on 09/11/2022)
14-Jul-2022 02-Aug-2022 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2022 inter alia to consider and approve Pursuant to Regulation 29 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that a Meeting of the Board of Directors of the Company will be held on Tuesday 2nd August 2022 interalia to consider and approve the Unaudited Financial Results for the First Quarter ended 30th June 2022. Pursuant to Regulation 33 and Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis and Limited Review Report for the first quarter ended 30th June, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 2nd August, 2022. Further, the Board Directors at its aforesaid meeting, has approved the appointment of Mr. David Rasquinha as an Additional Directors in the capacity of Independent Director of the Company for a period of 5 years subject to approval of members of the Company. A separate letter in this regard is being issued by the Company pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 along with the details prescribed in the SEBI circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015. Pursuant to Regulation 33 and Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis and Limited Review Report for the first quarter ended 30th June, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 2nd August, 2022. Further, the Board Directors at its aforesaid meeting, has approved the appointment of Mr. David Rasquinha as an Additional Directors in the capacity of Independent Director of the Company for a period of 5 years subject to approval of members of the Company. A separate letter in this regard is being issued by the Company pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 along with the details prescribed in the SEBI circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015. We wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 2nd August, 2022, has considered and approved, the appointment of Mr. David Rasquinha (DIN: 01172654) as an Additional Director in the capacity of Independent Director of the Company for a period of 5 years, subject to approval of members of the Company, by means of an ordinary resolution at the ensuing Annual General Meeting. Kindly take the information on record. (As Per BSE Announcement Dated on 02.08.2022)
16-May-2022 27-May-2022 ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 inter alia to consider and approve he Audited Financial Results for the Financial Year ended 31st March 2022 and recommend dividend if any. We wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Audited Standalone and Consolidated Financial Results, Segment wise revenue results, Capital Employed and Statement of Assets & Liabilities and Cash flow Statement and Auditor's Report dated May 27, 2022 on Standalone and Consolidated Financial Results for the financial year ended March 31, 2022 duly approved by the Board of Directors at its meeting held today i.e. May 27, 2022. The Board of Directors has recommended a Final Dividend of Rs. 10/- (Rupees Ten) per Equity Share of face value of Rs.10/- each for the financial year 2021-22. Ion Exchange India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2022, inter alia, has recommended a Dividend of Rs.10/- (Rupees Ten) per Equity Share of face value of Rs. 10/- each for the financial year 2021-22. The Dividend if approved by the Shareholders at the ensuing Annual General Meeting (AGM) will be creruted within 30 days from the date of AGM. (As Per BSE Announcement Dated on 27.05.2022) Pursuant to Regulation 47(1)(b) read with regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith newspaper advertisement published on 29th May, 2022, in Free press journal (English) and Navshakti (Regional language), pertaining to Audited Financial Results for the financial year ended March 31, 2022.. (As Per BSE Announcement Dated on 30/05/2022)
15-Mar-2022 14-Mar-2022 This is to inform you that the Board of Directors at their meeting held on March 14, 2022 has considered and approved Re-appointment of Mr. Rajesh Sharma (DIN: 00515486) as Chairman and Managing Director for the period of five years effective from 1st April 2022 to 31st March, 2027 and remuneration payable to him, subject to the approval of the shareholders.
1 2 3  Next